Multivariate survival analysis using Cox's regression model

[1]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[2]  N. Draper,et al.  Applied Regression Analysis , 1966 .

[3]  P Armitage,et al.  Statistical methods for the identification and use of prognostic factors , 1974, International journal of cancer.

[4]  N. Breslow.  Covariance analysis of censored survival data. , 1974, Biometrics.

[5]  M. Pike,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.

[6]  R. Kay,et al.  Proportional Hazard Regression Models and the Analysis of Censored Survival Data , 1977 .

[7]  D. Byar,et al.  Selecting optimal treatment in clinical trials using covariate information. , 1977, Journal of chronic diseases.

[8]  C F Starmer,et al.  Clinical Judgment and Statistics: Lessons from a Simulated Randomized Trial in Coronary Artery Disease , 1980, Circulation.

[9]  C F Starmer,et al.  On the complexity of investigating chronic illness. , 1980, Biometrics.

[10]  D. Byar.  Why data bases should not replace randomized clinical trials. , 1980, Biometrics.

[11]  A. Atkinson.  A note on the generalized information criterion for choice of a model , 1980 .

[12]  E. Christensen,et al.  Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients , 1980 .

[13]  S. Borowsky,et al.  Continued heavy drinking and survival in alcoholic cirrhotics , 1981 .

[14]  E. Christensen,et al.  Aspects of the natural history of gastrointestinal bleeding in cirrhosis and the effect of prednisone. , 1981, Gastroenterology.

[15]  J. Kalbfleisch,et al.  The Statistical Analysis of Failure Time Data , 1980 .

[16]  P. Peduzzi,et al.  Validation of a risk function to predict mortality in a VA population with coronary artery disease. , 1982, Controlled clinical trials.

[17]  Per Kragh Andersen,et al.  Testing Goodness of Fit of Cox's Regression and Life Model , 1982 .

[18]  W. Dixon,et al.  BMDP statistical software , 1983 .

[19]  John A. Lewis.  Clinical trials: Statistical developments of practical benefit to the pharmaceutical industry , 1983 .

[20]  J. Elashoff.  Surviving Proportional Hazards , 2007, Hepatology.

[21]  N Tygstrup,et al.  Prognostic Factors in Cirrhosis Identified by Cox's Regression Model , 2007, Hepatology.

[22]  S. Schenker.  Alcoholic Liver Disease: Evaluation of Natural History and Prognostic Factors , 1984, Hepatology.

[23]  D. V. van Thiel,et al.  Medical Aspects of Liver Transplantation , 1984, Hepatology.

[24]  A fair trial? , 1984, British medical journal.

[25]  Copenhagen Esophageal Varices Sclerotherapy.  Sclerotherapy after first variceal hemorrhage in cirrhosis. A randomized multicenter trial. , 1984, The New England journal of medicine.

[26]  E. Christensen,et al.  Prognostic Value of Child‐Turcotte Criteria in Medically Treated Cirrhosis , 1984, Hepatology.

[27]  N Tygstrup,et al.  Changes of laboratory variables with time in cirrhosis: Prognostic and therapeutic significance , 1985, Hepatology.

[28]  D. Altman,et al.  Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial. , 1985, Gastroenterology.

[29]  P. Andersen,et al.  A therapeutic index that predicts the individual effects of prednisone in patients with cirrhosis. , 1985, Gastroenterology.

[30]  D. Altman.  Comparability of Randomised Groups , 1985 .

[31]  C. Gluud.  Testosterone treatment of men with alcoholic cirrhosis: A double‐blind study , 1986, Hepatology.

[32]  N Tygstrup,et al.  Updating prognosis and therapeutic effect evaluation in cirrhosis with Cox's multiple regression model for time-dependent variables. , 1986, Scandinavian journal of gastroenterology.

[33]  V. Arroyo,et al.  Compensated cirrhosis: Natural history and prognostic factors , 1987, Hepatology.